CIOApplications
static-image
  • Home
  • Applications
      • Bioinformatics
      • Business Continuity
      • Business Intelligence
      • Chatbot
      • Collaboration
      • Custom Software Development
      • CRM
      • Enterprise Reporting Software
      • GRC
      • Human Resource
      • Indoor Positioning
      • InsurTech
      • Intellectual Property
      • IT Operations Management
      • IT Service Management
      • Low Code Platform
      • Maintenance Management
      • Managed IT Services
      • MarTech
      • Master Data Management
      • Mobile Application
      • Order Management
      • Parking Management
      • Procurement Tech
      • Publishing Software
      • Remote Monitoring
      • RFID
      • Sales Tech
      • SAS
      • Software Testing
      • Task Management
      • Unified Communications
      • Workflow
      • Workplace Management
  • Verticals
      • BioTechnology
      • Construction
      • Contact Center
      • Education
      • Fintech
      • Food and Beverages
      • Government
      • Healthcare
      • Legal
      • Logistics
      • Manufacturing
      • Travel and Hospitality
      • Utilities
  • Technologies
      • Agile
      • API
      • Artificial Intelligence
      • Blockchain
      • CAD/CAM
      • Cloud
      • Cyber Security
      • Data Analytics
      • Data Center
      • Digital Transformation
      • Graphics
      • IoT
      • Machine Learning
      • Machine Vision and Imaging
      • Predictive Analytics
      • Robotic Process Automation
      • Simulation
      • Smart Labelling
  • Eco System
      • Adobe
      • Amazon
      • Esri
      • Google
      • IBM
      • Infor
      • Kubernetes Partner
      • NetSuite
      • Oracle
      • PTC Partners
      • Qlik Partner
      • Salesforce
      • ServiceNow
      • SiteCore
      • VMware
  • Vendors
  • News
  • Newsletter
  • Whitepaper
  • conferences
  • About Us
  • Specials

  • Menu
      • Business Continuity
      • Chatbot
      • Cloud
      • Collaboration
      • Contact Center
      • Esri
      • Human Resource
      • InsurTech
      • IT Service Management
      • Machine Learning
      • Manufacturing
      • Master Data Management
      • Procurement Tech
      • Robotic Process Automation
      • Salesforce
      • ServiceNow
      • Simulation
      • Software Testing
  • Contact Center
  • Collaboration
  • Chatbot
  • Esri
  • Simulation
  • InsurTech
  • Human Resource
Specials
  • Specials

  • Business Continuity
  • Chatbot
  • Cloud
  • Collaboration
  • Contact Center
  • Esri
  • Human Resource
  • InsurTech
  • IT Service Management
  • Machine Learning
  • Manufacturing
  • Master Data Management
  • Procurement Tech
  • Robotic Process Automation
  • Salesforce
  • ServiceNow
  • Simulation
  • Software Testing
×
#

CIO Applications Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from CIO Applications

Subscribe

loading
  • Home
  • BioTechnology
Editor's Pick (1 - 4 of 8)
left
Formula Five for Biotech IT

Formula Five for Biotech IT
Jeffrey Keisling, CIO & SVP, Pfizer [NYSE:PFE]

Being a Biotech CIO, or How to StopWorrying and Love Rapid Change

Being a Biotech CIO, or How to StopWorrying and Love Rapid Change
R. Mark Adams, CIO, Good Start Genetics, Cambridge, MA

The Changing Role of CIO in the Biopharmaceutical Industry

The Changing Role of CIO in the Biopharmaceutical Industry
Andy Newsom, CIO, CSL Behring

Advanced Therapies for Patients Suffering from PAH

Advanced Therapies for Patients Suffering from PAH
Shola Oyewole, CIO, United Therapeutics Corporation [NASDAQ:UTHR]

How to Nurture a Biotech?  Sometimes, Like a Teenager

How to Nurture a Biotech? Sometimes, Like a Teenager
Nicholas Ventresca, SVP & CIO, ARIAD Pharmaceuticals, Inc. [NASDAQ:ARIA]

Pioneering Production and Delivery Solutions to Address the Complexities of Cell Therapy

Pioneering Production and Delivery Solutions to Address the...
Christina Yi, Chief Operations Officer, Dendreon

Digital Therapy - 21st Century Medicine?

Digital Therapy - 21st Century Medicine?
Daniel Schoener, Senior Director R&D & IVD Advisor/Freelance

Snakebite911 App Suite

Snakebite911 App Suite
Amanda L. Goltz, Vice President, Digital Innovation, BTG

right

Thank you for Subscribing to CIO Applications Weekly Brief

Kinnate Biopharma Secures $98 Million in Series C Round of Financing

By CIO Applications| Tuesday, September 01, 2020
Tweet

Kinnate Biopharma raises $98 million in Series C financing round

Fremont, CA: Kinnate Biopharma, a biopharmaceutical company, working on discovering and developing small molecule kinase inhibitors for genomically-defined cancers that are difficult-to-treat, raised $98 million in Series C round of financing. The financing round was led by RA Capital Management with participation from additional new investors including Viking Global Investors, Venrock Healthcare Capital Partners, Fidelity Management & Research Company, LLC, Janus Henderson Investors, Surveyor Capital (a Citadel company), Boxer Capital of Tavistock Group, Logos Capital, and an investment fund affiliated with SVB Leerink. Existing investors of the company, Foresite Capital, OrbiMed, Nextech Invest, and Vida Ventures, also actively participated in the round. Last year, Kinnate closed a $74.5 million Series B funding round.

“In just over two years, Kinnate has built a proprietary pipeline of kinase inhibitors from the ground up, and this significant financing positions us to advance at least one of our lead product candidates into clinical development in the first half of next year,” said Nima Farzan, CEO of Kinnate. “We are pleased to expand our syndicate of world-class healthcare investors during this exciting time of growth for the company. Their expertise will be invaluable as we execute on our vision of increasing the availability of targeted therapies for the many cancer patients who currently lack access to effective precision medicines.”

Kinnate developed a wholly-owned kinase inhibitor portfolio through its deep expertise in structure-based drug discovery, translational research, and patient-driven precision medicine. The company’s leading preclinical program includes small molecule inhibitors targeting specific classes of BRAF kinase mutations (Class II and Class III mutations) and FGFR2 or FGFR3 alterations that will help to tackle resistance that commonly limits the efficacy of existing therapies. The company is also developing several other research programs. To help promote these programs, Kinnate is working with leaders at experienced precision medicine cancer centers, including the Massachusetts General Hospital Cancer Center and the UC San Diego Moores Cancer Center.

“The rapid advancement of genomic technologies has enabled the identification of many more people who may benefit from genomically-targeted therapies. However, because of non-response or resistance mutations, many fail to benefit from these potentially life-saving medicines,” said Peter Kolchinsky, Ph.D., managing partner at RA Capital Management. “We are proud to support the Kinnate team and see tremendous potential for their lead programs to significantly increase the number of people who could benefit from targeted precision oncology therapeutics.”

See also: Top Oncology Solution Companies

tag

Oncology

Biotech

Weekly Brief

loading
ON THE DECK

Top Vendors

Field Service 2021

Top Vendors

Previous Next
Tweets by CIOApplications

Read Also

EPAM to Acquire PolSource to Scale its Salesforce Capabilities and Expand into New Markets

EPAM to Acquire PolSource to Scale its Salesforce Capabilities and Expand into New Markets

Destaco Launches TC1 Manual Tool Changer for Cobots

Destaco Launches TC1 Manual Tool Changer for Cobots

Four Business Challenges in Procurement

Four Business Challenges in Procurement

Five Trends Set to Transform the Contact Center

Five Trends Set to Transform the Contact Center

How the Weaponization of Artificial intelligence (AI) can Impact the Future of Humanity

How the Weaponization of Artificial intelligence (AI) can Impact the Future of Humanity

Four Benefits of Cloud-Based Business Budgeting Software

Four Benefits of Cloud-Based Business Budgeting Software

Loading...

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Copyright © 2021 CIOApplications. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy Policy |  Sitemap  |  Subscribe |  About Us

follow on linkedin follow on twitter follow on rss
This content is copyright protected close

However, if you would like to share the information in this article, you may use the link below:

https://www.cioapplications.com/news/kinnate-biopharma-secures-98-million-in-series-c-round-of-financing-nid-6392.html